Radiochemotherapy of postoperative minimal residual disease in neuroblastoma.
D000367:Age Factors; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009367:Neoplasm Staging; D009422:Nervous System Diseases / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy*; D009447:Neuroblastoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D011184:Postoperative Period; D011446:Prospective Studies; D012189:Retrospective Studies; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide